speb/financial-data huggingface dataset:
Financial scorecard for INIO (Industrials — Specialty Industrial Machinery, Germany)
Report date: 2026-03-31 (quarterly)
Stock price: 26.8
Market cap: 19710001152 (USD: 19710001152)
Debt to equity: 12.458499999999999
Current ratio: 1.33
Interest coverage ratio: 0.8912429378531073
Buffett classification: The Gruesome
Rule of 40 score: 63.67293163381967
Altman Z-score: 2.3484776216381618 (Grey Zone)
Piotroski F-score: 3 (Weak)
Magic formula: return on capital % 5.342477351621371, earnings yield % 0.33234541528889233, rank 1716
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -26.53508771929824, 3m , 6m , 12m , composite  ()
Lynch category: Speculative (confidence: Low)
Screener: long score 3, short score 6, recommendation: Neutral
Revenue deceleration: no
Accrual ratio: -0.027334076860550838
FCF conversion rate: -19.083333333333332
Beneish M-score: -0.23365276276347707 (Strong Manipulation Signal)
ROE (%): -3.0482641828958448
Net margin (%): -1.0768770565360453
Asset turnover: 0.12638702481994668
Equity multiplier (leverage): 22.39669771380182
ROE archetype: Low Return
P/E z-score: -1.7359026723741424
FCF z-score: -1.7359026723741409
Treasury beta 1y: -0.07946497458334636 (R-squared: 0.0043906133190687365)
Insider 90-day net shares: 74074 (net value USD: 1999998.00)
ROIC (%): 11.767814106201833 (pretax: 15.286539903824947)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC 32.177263969171484, revenue growth 1y , 6m momentum 
Industry median P/E: 0.34832165205981025; industry median ROIC: 8.620128805291433
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.05
Base cash flow: 172705882.35294122
DCF price per share: base 24.179562340913265, conservative 9.876604029754603, aggressive 55.741620772141815
Financial scorecard for INNV (Healthcare — Medical Care Facilities, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 11.56
Market cap: 1569112832 (USD: 1569112832)
P/B ratio: 4.204832371008984
Debt to equity: 0.3625
Current ratio: 1.03
Interest coverage ratio: -29.432186234817813
Return on net tangible assets (%): -33.77950024521238
Buffett classification: The Gruesome
Analyst consensus upside (%): -12.718204488778051
Rule of 40 score: 10.16360442648215
Altman Z-score: 3.276900475483017 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.09642391350987307
Total shareholder yield (%): 0.09642391350987307 (Low Return)
Momentum (%): 1m 19.544984488107556, 3m 45.40880503144654, 6m 98.28473413379074, 12m 204.21052631578948, composite 99.38907445858786 (Strong Uptrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 7, short score 5, recommendation: Neutral
Revenue growth 1y (%): 15.494952828891261
Revenue deceleration: no
Accrual ratio: -0.08186618735556474
FCF conversion rate: -0.49343199484063677
Beneish M-score: -2.9677063423095285 (Likely Safe)
ROE (%): -10.758923925011459
Net margin (%): -11.693517978272864
Asset turnover: 0.468785236622643
Equity multiplier (leverage): 1.9626810211500993
ROE archetype: Low Return
FCF z-score: 2.737443233625986
Treasury beta 1y: 0.0018445994548084773 (R-squared: 9.506940478756728e-05)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -4.942263655279034 (pretax: -6.256029943391182)
Incremental ROIC 3y (%): -234.1479424387781 (pretax: -296.3898005554153)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 55.714285714285715, ROIC 69.04761904761905, revenue growth 1y 18.571428571428573, 6m momentum 2.380952380952381
Sector percentiles: P/E , 6m momentum 2.2564469914040113
Industry median P/E: 1.7425206697700268; industry median ROIC: 5.681103510179656
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.0615521395360988
Base cash flow: -17066000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for IPSC (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 2.08
Market cap: 380548640 (USD: 380548640)
P/B ratio: 1.539607576904481
Debt to equity: 0.1814
Current ratio: 10.25
Return on net tangible assets (%): -8.33897217017142
Buffett classification: The Gruesome
Analyst consensus upside (%): 110.1769911504425
Rule of 40 score: 0
Altman Z-score: 0.42794272477665096 (Distress Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -1.17199210066813
Total shareholder yield (%): -1.17199210066813 (Minimal or Negative)
Momentum (%): 1m -9.170305676855893, 3m -6.306306306306311, 6m -14.049586776859499, 12m 215.15151515151513, composite 75.5379346288437 (Strong Uptrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 10, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): -100
Net income growth 1y (%): -128.27194357366773
Revenue deceleration: no
Accrual ratio: 0.015269228742205914
FCF conversion rate: 1.1940863940863942
Beneish M-score: -1.8284219098774122 (Likely Safe)
ROE (%): -10.217617069486405
Asset turnover: 0
Equity multiplier (leverage): 1.2987561367069487
ROE archetype: Low Return
Treasury beta 1y: -0.0008532164135451642 (R-squared: 1.451967537497535e-05)
Insider 90-day net shares: -5275 (net value USD: -11709.00)
ROIC (%): -9.720144752714113 (pretax: -12.30398069963812)
Incremental ROIC 3y (%): 183.70867789793363 (pretax: 232.54263025054888)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E , P/B 17.418772563176894, ROIC 12.274368231046932, revenue growth 1y 29.693140794223826, 6m momentum 37.545126353790614
Sector percentiles: P/E , 6m momentum 43.83954154727794
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.11716487740171304
Base cash flow: 2673000
DCF price per share: base 0.5671061513107717, conservative 0.5532841435073695, aggressive 0.5829342875601693
Financial scorecard for IPX (Basic Materials — Other Industrial Metals & Mining, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 21.56
Market cap: 780761088 (USD: 780761088)
Debt to equity: 0.0412
Current ratio: 4.03
Buffett classification: The Gruesome
Analyst consensus upside (%): 124.27035330261135
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -22.16606498194946, 3m -26.741420319401975, 6m -64.13242388953584, 12m -47.26027397260275, composite -41.03818290330543 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 2, short score 4, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.48 (Likely Safe)
ROE archetype: Standard Business
Treasury beta 1y: -0.0020956560615153826 (R-squared: 0.00013429973939686437)
Insider 90-day net shares: 27987 (net value USD: 661660.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y , 6m momentum 75.93671940049958
Sector percentiles: P/E , 6m momentum 79.84453081621321
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.12060000000000001
Base cash flow: 0
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for IVALUE.NS (Technology — Information Technology Services, India)
Report date: 2026-03-31 (annual)
Stock price: 2.9696531791907517
Market cap: 15717160960 (USD: 166565927.93556592)
P/E ratio: 0.12700214840948923
P/B ratio: 2.075364307608451
Debt to equity: 0.1222
Current ratio: 1.55
Interest coverage ratio: 11.32
Return on net tangible assets (%): 18.765621652503032
Buffett classification: The Great
Analyst consensus upside (%): 16365.961280783626
Rule of 40 score: 13.65079799373501
Altman Z-score: 2.4873699985925852 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Magic formula: return on capital % 10.786378975355355, earnings yield % 0.04153851076409849, rank 1461
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.5172217155820326
Total shareholder yield (%): 0.5172217155820326 (Low Return)
Momentum (%): 1m 4.138084737814364, 3m 9.430306861522235, 6m 20.63063224787278, 12m , composite 15.030469554697508 (Moderate Uptrend)
Lynch category: Turnaround (confidence: Medium)
Screener: long score 3, short score 5, recommendation: Neutral
Revenue growth 1y (%): 3.7082082783232773
Net income growth 1y (%): 4.211548636880269
Revenue CAGR 3y (%): 4.847577200643394
Net income CAGR 3y (%): 12.579326780058441
Revenue deceleration: yes
Revenue growth consistency score: 9.521412543263285
Accrual ratio: -0.006895600066450663
FCF conversion rate: 1.095446228908315
Beneish M-score: -2.305219953315313 (Likely Safe)
ROE (%): 7.519526084733512
Net margin (%): 15.645634629493765
Asset turnover: 0.1891846875607251
Equity multiplier (leverage): 2.5404538161815267
ROE archetype: Standard Business
P/E z-score: 2.144411199702063
FCF z-score: 2.1444111997020627
Treasury beta 1y: -0.003625755627872949 (R-squared: 9.068118914860498e-06)
Insider 90-day net shares: -5698416 (net value USD: -15663236.00)
ROIC (%): 28.017410703686448 (pretax: 37.116376672204254)
Incremental ROIC 3y (%): 269.251105808278 (pretax: 341.79691171173386)
Capital allocation category: High-Efficiency Compounder
Industry percentiles: P/E 26.11464968152866, P/B 42.038216560509554, ROIC 20.169851380042463, revenue growth 1y 25.05307855626327, 6m momentum 7.43099787685775
Sector percentiles: P/E 14.247580914247582, 6m momentum 18.585251918585254
Industry median P/E: 0.21619799348899724; industry median ROIC: 12.533738935242045
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.10190961992203282
Base cash flow: 11139253.92115303
DCF price per share: base 0.02900918313469011, conservative 0.024219555566832904, aggressive 0.035175471841425596
Financial scorecard for IVQ.TO (Real Estate — Real Estate Services, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 0.0921985815602837
Market cap: 115314872 (USD: 82960339.56834532)
Debt to equity: 0.06480000000000001
Current ratio: 7.33
Interest coverage ratio: -7.526132404181184
Return on net tangible assets (%): 0.657630415935379
Buffett classification: The Gruesome
Rule of 40 score: -141.77134240984213
Altman Z-score: 1.3640862852050113 (Distress Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 24.086383655485324
Total shareholder yield (%): 24.086383655485324 (High Return)
Momentum (%): 1m 9.101654846335709, 3m -2.8368794326241, 6m -2.127659574468093, 12m -10.435663627152989, composite -7.62399455836675 (Strong Downtrend)
Lynch category: Turnaround (confidence: Low)
Screener: long score 2, short score 10, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): -92.96485148210058
Revenue deceleration: no
Accrual ratio: 0.028245027766425495
FCF conversion rate: -10.059800664451826
Beneish M-score: -6.901070703779301 (Likely Safe)
ROE (%): 0.3164434448756126
Net margin (%): 11.771607352366054
Asset turnover: 0.0216949642531541
Equity multiplier (leverage): 1.239085849317838
ROE archetype: Low Return
Treasury beta 1y: 0.019542960674097984 (R-squared: 0.007956997342301302)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): 11.771419513355001 (pretax: 14.900531029563293)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC 17.6056338028169, revenue growth 1y 48.35680751173709, 6m momentum 32.629107981220656
Sector percentiles: P/E , 6m momentum 36.64596273291926
Industry median P/E: 0.9094611103569973; industry median ROIC: 3.7422962097312933
Sector median P/E: 4.332660990050401; sector median ROIC: 3.0025005588392872
WACC: 0.15
Base cash flow: -23708029.19708029
Financial scorecard for IVR.AX (Basic Materials — Other Precious Metals & Mining, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.02777777777777778
Market cap: 101457560 (USD: 66312130.71895425)
Debt to equity: 0.0025
Current ratio: 15.15
Buffett classification: The Gruesome
Analyst consensus upside (%): 1506.4999999999998
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -19.444444444444436, 3m -35.18518518518518, 6m -72.96296296296296, 12m 39.81481481481482, composite -11.528309919114525 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.48 (Likely Safe)
ROE archetype: Standard Business
Treasury beta 1y: 0.002016036456568392 (R-squared: 3.52581641181759e-05)
Insider 90-day net shares: 250000 (net value USD: 14400.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y , 6m momentum 77.07736389684814
Sector percentiles: P/E , 6m momentum 82.3153803442532
Industry median P/E: 8.740359897172237; industry median ROIC: -12.638421644657798
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.1272
Base cash flow: 0
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for JUMP.V (Healthcare — Diagnostics & Research, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 0.03546099290780142
Market cap: 6097560 (USD: 4386733.812949641)
P/B ratio: 2.9513253477113146
Debt to equity: 2.96
Current ratio: 0.21
Interest coverage ratio: -0.5780188251874968
Buffett classification: The Gruesome
Rule of 40 score: -2.3508438191529697
Altman Z-score: -1.3284556814903423 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 9.414078662456953
Total shareholder yield (%): 9.414078662456953 (Moderate Return)
Momentum (%): 1m 0.7092198581560311, 3m -30.597771023302933, 6m -2.1276595744681, 12m -3.546099290780138, composite -12.316927570149028 (Moderate Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 3, short score 7, recommendation: Neutral
Revenue growth 1y (%): 5.6241740207157775
Net income growth 1y (%): -292.8247699298754
Revenue deceleration: no
Revenue growth consistency score: 2.1781659105992532
Accrual ratio: -0.03914782809834393
FCF conversion rate: -0.9773357841898475
Beneish M-score: -2.089627370963927 (Likely Safe)
ROE (%): -11.885000883728768
Net margin (%): -7.992542451006947
Asset turnover: 0.2477092903113426
Equity multiplier (leverage): 6.0030501522302835
ROE archetype: Low Return
FCF z-score: 3.4271356453609276
Treasury beta 1y: 0.0016161863163811842 (R-squared: 4.686060376209494e-05)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): 0.5737132092014687 (pretax: 0.7262192521537578)
Incremental ROIC 3y (%): 42.41893568817975 (pretax: 43.34494269829478)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E , P/B 46.32352941176471, ROIC 43.38235294117647, revenue growth 1y 38.970588235294116, 6m momentum 32.35294117647059
Sector percentiles: P/E , 6m momentum 32.05587392550143
Industry median P/E: 21.640734060420083; industry median ROIC: 2.9089897435686405
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.10400506054513996
Base cash flow: -1258704.3795620436
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for KLTR (Technology — Software - Application, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 1.4
Market cap: 210524624 (USD: 210524624)
P/B ratio: 39.50413118863049
Debt to equity: 9.587200000000001
Current ratio: 0.81
Interest coverage ratio: -1.6488970588235294
Buffett classification: The Gruesome
Analyst consensus upside (%): 186.88524590163937
Rule of 40 score: -9.70639585748587
Altman Z-score: -3.3500866795147584 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.8602319128236514
Total shareholder yield (%): 0.8602319128236514 (Low Return)
Momentum (%): 1m 3.7037037037036904, 3m 9.374999999999991, 6m -12.50000000000001, 12m -27.46113989637306, composite -11.058937823834201 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 1, short score 15, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): -5.018729780350761
Revenue deceleration: no
Accrual ratio: -0.025247871097783106
FCF conversion rate: -0.08676041390289202
Beneish M-score: -2.595509167109611 (Likely Safe)
ROE (%): -68.6771137026239
Net margin (%): -8.445749114865773
Asset turnover: 0.2750760487328293
Equity multiplier (leverage): 29.561133381924197
ROE archetype: Low Return
FCF z-score: 2.922505188109246
Treasury beta 1y: 0.014790744890055921 (R-squared: 0.01129067698524691)
Insider 90-day net shares: -536675 (net value USD: -787880.00)
ROIC (%): -364.58449809402794 (pretax: -461.49936467598474)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B 74.25876010781671, ROIC 77.49326145552561, revenue growth 1y 47.304582210242586, 6m momentum 38.14016172506739
Sector percentiles: P/E , 6m momentum 45.545545545545544
Industry median P/E: 2.1394954536591486; industry median ROIC: 6.21806735836372
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.09970296489907292
Base cash flow: -8230000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for KLV.AX (Technology — Software - Application, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.034722222222222224
Market cap: 80338184 (USD: 52508616.99346405)
Current ratio: 0.82
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -28.07539682539683, 3m 21.527777777777775, 6m 406.94444444444446, 12m 424.3055555555556, composite 352.4792464878672 (Strong Uptrend)
Lynch category:  (confidence: Low)
Screener: long score 0, short score 3, recommendation: Neutral
Revenue deceleration: no
Revenue growth consistency score: 69.51061336197021
Beneish M-score: -2.48 (Likely Safe)
ROE archetype: Standard Business
Treasury beta 1y: 0.056768245666740665 (R-squared: 0.011756803381127678)
Insider 90-day net shares: 5122894 (net value USD: 734072.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y , 6m momentum 0.2695417789757413
Sector percentiles: P/E , 6m momentum 0.3003003003003003
Industry median P/E: 2.1394954536591486; industry median ROIC: 6.21806735836372
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.13545000000000001
Base cash flow: 0
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for KROS (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 10.06
Market cap: 199105872 (USD: 199105872)
P/B ratio: 0.764982251444176
Debt to equity: 0.0571
Current ratio: 22.62
Return on net tangible assets (%): -8.184714490774779
Buffett classification: The Gruesome
Analyst consensus upside (%): 97.73550724637681
Rule of 40 score: 9587.620062142287
Altman Z-score: 3.0097623730967955 (Safe Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.28728434488361043
Total shareholder yield (%): 0.28728434488361043 (Low Return)
Momentum (%): 1m -7.87545787545787, 3m -12.597741094700254, 6m -47.604166666666664, 12m -30.04172461752434, composite -28.087701289023098 (Strong Downtrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 4, short score 8, recommendation: Short
Revenue growth 1y (%): -96.80108925159809
Net income growth 1y (%): -115.97025281069176
Revenue deceleration: no
Accrual ratio: -0.06183474444652891
FCF conversion rate: 0.1519318373544795
Beneish M-score: 105.86630936563974 (Strong Manipulation Signal)
ROE (%): -8.053508888141558
Net margin (%): -6459.945504087193
Asset turnover: 0.00112868552729912
Equity multiplier (leverage): 1.1045447905945016
ROE archetype: Low Return
P/E z-score: 1.3875534581872886
FCF z-score: 1.3875534581872897
Treasury beta 1y: 0.006422064082519554 (R-squared: 0.0032566794777771683)
Insider 90-day net shares: -5425 (net value USD: -58614.00)
ROIC (%): 196.25362664295204 (pretax: 207.26687116564415)
Incremental ROIC 3y (%): 711.2400032711597 (pretax: 836.289899327258)
Capital allocation category: High-Efficiency Compounder
Industry percentiles: P/E , P/B 8.483754512635379, ROIC 0.18050541516245489, revenue growth 1y 29.15162454873646, 6m momentum 64.89169675090253
Sector percentiles: P/E , 6m momentum 69.16189111747852
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.09876596773333444
Base cash flow: 86972000
DCF price per share: base 72.5492572467059, conservative 66.64289809641389, aggressive 79.48873716928865
Financial scorecard for LBRX (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 35.01
Market cap: 1003969536 (USD: 1003969536)
P/B ratio: 1.8673866121634148
Debt to equity: 0.0092
Current ratio: 35.68
Return on net tangible assets (%): -5.0183129870369925
Buffett classification: The Gruesome
Analyst consensus upside (%): 86.05028386050286
Rule of 40 score: 0
Altman Z-score: 41.17100812053378 (Safe Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.009860856973253817
Total shareholder yield (%): 0.009860856973253817 (Low Return)
Momentum (%): 1m 14.862204724409441, 3m 13.927757891311416, 6m 46.42409033877038, 12m , composite 30.175924115040896 (Strong Uptrend)
Lynch category: Turnaround (confidence: Medium)
Screener: long score 4, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: 0.012083531516839935
FCF conversion rate: 1.2239949616878345
Beneish M-score: -2.548974965059832 (Likely Safe)
ROE (%): -5.604092923119457
Asset turnover: 0
Equity multiplier (leverage): 1.0388424756949601
ROE archetype: Low Return
Treasury beta 1y: -0.0031240392551738893 (R-squared: 0.0005572165548297989)
Insider 90-day net shares: 4999999 (net value USD: 74999985.00)
ROIC (%): -248.491206290089 (pretax: -314.54583074694807)
Incremental ROIC 3y (%): -61.00646443163373 (pretax: -77.22337269827055)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 22.021660649819495, ROIC 32.67148014440433, revenue growth 1y , 6m momentum 9.2057761732852
Sector percentiles: P/E , 6m momentum 7.091690544412607
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.10162728959870099
Base cash flow: -24936000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for LHAI (Real Estate — Real Estate Services, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 0.9
Market cap: 14913366 (USD: 14913366)
P/B ratio: 2.5770423754718004
Debt to equity: 0.051
Current ratio: 11.92
Interest coverage ratio: -392.4908424908425
Return on net tangible assets (%): -1.261121474913833
Buffett classification: The Gruesome
Rule of 40 score: -70.45397784872763
Altman Z-score: 13.868743262384882 (Safe Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.1931891163939784
Total shareholder yield (%): 0.1931891163939784 (Low Return)
Momentum (%): 1m 26.7605633802817, 3m -15.887850467289722, 6m -53.125, 12m -84.01420959147424, composite -52.13394601129906 (Strong Downtrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 4, short score 9, recommendation: Short
Revenue growth 1y (%): -14.046175570013519
Net income growth 1y (%): -267.02427166404146
Revenue deceleration: no
Accrual ratio: 0.3463270803879472
FCF conversion rate: 24.452335338234203
Beneish M-score: 0.679951094897747 (Strong Manipulation Signal)
ROE (%): -1.7785024262090534
Net margin (%): -2.7441838666359653
Asset turnover: 0.5381299324995074
Equity multiplier (leverage): 1.2043538510645857
ROE archetype: Low Return
P/E z-score: 1.8637549562336955
Treasury beta 1y: 0.009699159268899386 (R-squared: 0.00014056299831966486)
Insider 90-day net shares: -1580000 (net value USD: -2868334.00)
ROIC (%): 4.814576846406037 (pretax: 7.407041302163132)
Incremental ROIC 3y (%): -21.491345757156342 (pretax: -19.16667705696794)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 68.07511737089203, ROIC 36.38497652582159, revenue growth 1y 41.31455399061033, 6m momentum 88.26291079812206
Sector percentiles: P/E , 6m momentum 78.33850931677019
Industry median P/E: 0.9094611103569973; industry median ROIC: 3.7422962097312933
Sector median P/E: 4.332660990050401; sector median ROIC: 3.0025005588392872
WACC: 0.10159424276659575
Base cash flow: -181774
DCF price per share: base 0.033128173839618184, conservative 0.18817321275788035, aggressive 0
Financial scorecard for LIFE (Financial Services — Insurance Brokers, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 18.5
Market cap: 1758860288 (USD: 1758860288)
P/B ratio: 0.7824666207970127
Debt to equity: 0.004699999999999999
Current ratio: 1.67
Interest coverage ratio: -246.6978851963746
Return on net tangible assets (%): -37.66489982848593
Buffett classification: The Gruesome
Analyst consensus upside (%): 145.56848701880034
Rule of 40 score: -9.219288823121872
Altman Z-score: 4.963436496934235 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.017170209712529482
Total shareholder yield (%): 0.017170209712529482 (Low Return)
Momentum (%): 1m 2.2099447513812076, 3m 10.316040548598691, 6m , 12m , composite 10.316040548598691 ()
Lynch category: Speculative (confidence: Low)
Screener: long score 5, short score 7, recommendation: Neutral
Revenue growth 1y (%): 190.2696771090133
Net income growth 1y (%): -1842.67909509845
Revenue deceleration: no
Accrual ratio: -0.3448908567102699
FCF conversion rate: -0.17598908594815826
Beneish M-score: -3.5412626109298326 (Likely Safe)
ROE (%): -79.76424173132281
Net margin (%): -86.16875281591308
Asset turnover: 0.34035221613447064
Equity multiplier (leverage): 2.719755421169827
ROE archetype: Low Return
P/E z-score: 1.4077212603853175
FCF z-score: 1.4077212603853169
Treasury beta 1y: 0.011685229747139642 (R-squared: 0.005633290699835227)
Insider 90-day net shares: -545834 (net value USD: -11673286.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 17.94871794871795, ROIC , revenue growth 1y 0, 6m momentum 
Industry median P/E: 20.70740316505789; industry median ROIC: 7.665445948403268
Sector median P/E: 9.286368843069873; sector median ROIC: 1.3915857507207385
WACC: 0.15
Base cash flow: 75922000
DCF price per share: base 48.69463192896315, conservative 31.95124383326949, aggressive 76.53969093942254
Financial scorecard for LNTH (Healthcare — Drug Manufacturers - Specialty & Generic, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 104.82
Market cap: 6824419328 (USD: 6824419328)
P/E ratio: 18.102625298329354
P/B ratio: 4.073533945481602
Debt to equity: 0.5162
Current ratio: 2.83
Interest coverage ratio: 16.71998355263158
Return on net tangible assets (%): 51.670907803066356
Buffett classification: The Great
Analyst consensus upside (%): 48.09492419248518
Rule of 40 score: 20.814378764563685
Altman Z-score: 4.672563406742754 (Safe Zone)
Piotroski F-score: 8 (Strong)
Magic formula: return on capital % 10.607485473173467, earnings yield % 1.1698907343516833, rank 685
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.09260861175498974
Total shareholder yield (%): -0.09260861175498974 (Minimal or Negative)
Momentum (%): 1m -0.028612303290415964, 3m 24.297403059409454, 6m 55.26588653532808, 12m 47.77950091639642, composite 42.46169524392468 (Strong Uptrend)
Lynch category: Fast Grower (confidence: Medium)
Screener: long score 10, short score 0, recommendation: Strong Long (L/S Compounder)
Revenue growth 1y (%): 1.225708491163302
Net income growth 1y (%): 62.33737747618069
Revenue deceleration: no
Accrual ratio: -0.0015233977541689021
FCF conversion rate: 1.0294214513118893
Beneish M-score: -2.6093316266291127 (Likely Safe)
ROE (%): 10.287804316521761
Net margin (%): 31.382624896311746
Asset turnover: 0.16499088541154258
Equity multiplier (leverage): 1.9868884076826008
ROE archetype: Standard Business
P/E z-score: 4.526807651612898
FCF z-score: 4.526807651612894
Treasury beta 1y: 0.0016073135254262793 (R-squared: 0.00022583568711550305)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): 17.396697038541763 (pretax: 23.372870911067857)
Incremental ROIC 3y (%): 28.06131756050026 (pretax: 38.00327844321559)
Capital allocation category: High-Efficiency Compounder
Industry percentiles: P/E 44.28152492668622, P/B 63.929618768328446, ROIC 13.48973607038123, revenue growth 1y 41.348973607038126, 6m momentum 6.451612903225806
Sector percentiles: P/E 22.52865329512894, 6m momentum 5.515759312320917
Industry median P/E: 0.8814835040505258; industry median ROIC: 5.747543732928968
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.05
Base cash flow: 262155000
DCF price per share: base 474.7226359965867, conservative 224.62096650309627, aggressive 1026.6170996854692
Financial scorecard for LUCD (Healthcare — Medical Devices, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 0.91
Market cap: 173144240 (USD: 173144240)
P/B ratio: 54.846818612499995
Debt to equity: 6.7008
Current ratio: 1.07
Interest coverage ratio: -2019
Return on net tangible assets (%): -366.8073878627968
Buffett classification: The Gruesome
Analyst consensus upside (%): 243.47826086956528
Rule of 40 score: -1109.4033744409812
Altman Z-score: -9.853132511737089 (Distress Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0.009818403430573261
Debt paydown yield (%): -0.5677347395443244
Total shareholder yield (%): -0.5579163361137511 (Minimal or Negative)
Momentum (%): 1m -10.784313725490195, 3m -14.953271028037385, 6m -24.79338842975206, 12m -17.272727272727277, composite -15.673128910172244 (Moderate Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 0, short score 13, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): 51.69082125603865
Revenue deceleration: no
Accrual ratio: -0.042750754780275076
FCF conversion rate: 0.8854698396721548
Beneish M-score: -2.672625815836873 (Likely Safe)
ROE (%): -186.2479914301018
Net margin (%): -1107.404458598726
Asset turnover: 0.03370680979537068
Equity multiplier (leverage): 4.989622388859132
ROE archetype: Low Return
Treasury beta 1y: 0.002557545437643359 (R-squared: 0.0002957478135981387)
Insider 90-day net shares: 245000 (net value USD: 245270.00)
ROIC (%): -1912.0234032179426 (pretax: -2420.2827888834713)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B 67.35905044510386, ROIC 71.51335311572701, revenue growth 1y 8.30860534124629, 6m momentum 49.554896142433236
Sector percentiles: P/E , 6m momentum 54.08309455587392
Industry median P/E: 21.626420273203117; industry median ROIC: -5.9391058628332924
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.09414376452692687
Base cash flow: -57335000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for MAG.AX (Basic Materials — Gold, Australia)
Report date: 2024-06-30 (annual)
Stock price: 0.020833333333333332
Market cap: 13560238 (USD: 9040158.666666666)
P/B ratio: 3.239377886968695
Debt to equity: 0.0558
Current ratio: 4.07
Interest coverage ratio: -75.68547832071576
Return on net tangible assets (%): -34.94418245002532
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 1.1548469871988973
Total shareholder yield (%): 1.1548469871988973 (Low Return)
Momentum (%): 1m 0.6944444444444402, 3m -2.7777777777777843, 6m -39.16666666666668, 12m -37.08333333333334, composite -26.48722860791827 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 2, short score 9, recommendation: Short
Net income CAGR 3y (%): nan
Revenue deceleration: no
Accrual ratio: -0.045278237999422634
FCF conversion rate: 0.8981670097238981
Beneish M-score: -2.187407525053123 (Likely Safe)
ROE (%): -49.67244961471643
Equity multiplier (leverage): 1.117157889110014
ROE archetype: Low Return
Treasury beta 1y: 0.0010423587730032493 (R-squared: 1.0213697661054758e-05)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -78.36911812338104 (pretax: -99.20141534605193)
Incremental ROIC 3y (%): 172.5666492244545 (pretax: 131.83305939150995)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E , P/B 33.14447592067989, ROIC 49.71671388101983, revenue growth 1y , 6m momentum 54.6742209631728
Sector percentiles: P/E , 6m momentum 62.74292059966685
Industry median P/E: 8.322060300477567; industry median ROIC: -7.9824265928961236
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.07997374289139998
Base cash flow: -2167089.3333333335
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for MEDP (Healthcare — Diagnostics & Research, United States)
Report date: 2026-06-30 (quarterly)
Stock price: 608
Market cap: 16785511424 (USD: 16785511424)
P/E ratio: 31.115746180963576
P/B ratio: 34.07020536865494
Debt to equity: 0.3322
Current ratio: 0.73
Return on net tangible assets (%): -39.810047965755125
Buffett classification: The Great
Analyst consensus upside (%): 7.756944051058352
Rule of 40 score: 19.01227968019597
Altman Z-score: 6.210831257055881 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 1.7560620737390527
Debt paydown yield (%): 0.012844410548714895
Total shareholder yield (%): 1.7689064842877675 (Low Return)
Momentum (%): 1m 18.567054739757026, 3m 48.09762751498026, 6m 3.392568659127633, 12m 33.42696629213483, composite 21.341038003728844 (Moderate Uptrend)
Lynch category: Fast Grower (confidence: High)
Screener: long score 8, short score 2, recommendation: Long
Revenue growth 1y (%): 17.241522199993042
Net income growth 1y (%): 34.458231774872594
Revenue deceleration: no
Revenue growth consistency score: 6.548371806531663
Accrual ratio: -0.007995616693823484
FCF conversion rate: 1.1379179644369737
Beneish M-score: -2.426114516232709 (Likely Safe)
ROE (%): 23.515779785404607
Net margin (%): 17.157738032123575
Asset turnover: 0.33788669803195476
Equity multiplier (leverage): 4.056283091530021
ROE archetype: Leverage-Driven Returns
P/E z-score: 5.480346202341921
FCF z-score: 5.480346202341925
Treasury beta 1y: -0.002093498044452156 (R-squared: 0.0001659872973318077)
Insider 90-day net shares: -16349 (net value USD: -7357050.00)
ROIC (%): 588.030269921314 (pretax: 706.9781272715259)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E 33.82352941176471, P/B 71.32352941176471, ROIC 0, revenue growth 1y 22.058823529411764, 6m momentum 23.52941176470588
Sector percentiles: P/E 28.116045845272208, 6m momentum 24.74928366762178
Industry median P/E: 21.640734060420083; industry median ROIC: 2.9089897435686405
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.10975771906826504
Base cash flow: 447891000
DCF price per share: base 487.0497260336657, conservative 291.2973611235704, aggressive 828.2745575362852
Financial scorecard for MEGASTAR.NS (Consumer Defensive — Packaged Foods, India)
Report date: 2026-03-31 (annual)
Stock price: 3.5177539223782
Market cap: 3848892928 (USD: 40789454.51462484)
P/E ratio: 0.3271246265793032
P/B ratio: 2.782271043424378
Debt to equity: 1.2773
Current ratio: 1.15
Interest coverage ratio: 1.8275871679812705
Return on net tangible assets (%): 10.13879896799983
Buffett classification: The Good
Rule of 40 score: 37.38787372120004
Altman Z-score: 2.10265278566791 (Grey Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -2.9788993532433925, 3m 23.00049104031671, 6m 47.077742880016444, 12m 10.985553731413724, composite 28.157148771984794 (Moderate Uptrend)
Lynch category: Fast Grower (confidence: Medium)
Screener: long score 7, short score 0, recommendation: Neutral
Revenue growth 1y (%): 33.73516384176847
Net income growth 1y (%): 122.19465568675227
Revenue CAGR 3y (%): 15.060244061024818
Net income CAGR 3y (%): -7.081304033759994
Revenue deceleration: no
Revenue growth consistency score: 26.54105287444384
Beneish M-score: 4.872556674832463 (Strong Manipulation Signal)
ROE (%): 2.1782241742346033
Net margin (%): 1.5340651185208565
Asset turnover: 0.5446795419203991
Equity multiplier (leverage): 2.6068600403234434
ROE archetype: Low Return
P/E z-score: 5.005759895334722
FCF z-score: 2.6528384112163583
Treasury beta 1y: 0.0008281440505944576 (R-squared: 6.175710970060388e-05)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): 8.765363331505482 (pretax: 11.702426211778544)
Incremental ROIC 3y (%): 2.644749560316907 (pretax: 3.2794273915753602)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 29.274004683840747, P/B 55.73770491803278, ROIC 28.805620608899297, revenue growth 1y 5.386416861826698, 6m momentum 2.810304449648712
Sector percentiles: P/E 25.05430847212165, 6m momentum 2.606806661839247
Industry median P/E: 0.5444598070416563; industry median ROIC: 6.765322712696236
Sector median P/E: 1.0302878025850322; sector median ROIC: 7.163828537874342
WACC: 0.05
Base cash flow: 1105298.8554472234
DCF price per share: base 0.08272779951831517, conservative 0.033117690748081664, aggressive 0.18843869230238153
Financial scorecard for MSI.AX (Industrials — Specialty Industrial Machinery, Australia)
Report date: 2025-12-31 (annual)
Stock price: 0
Market cap: 408911 (USD: 274436.91275167785)
P/E ratio: 0
Debt to equity: -0.5411000542948203
Current ratio: 0.44
Interest coverage ratio: -27.237725350187354
Return on net tangible assets (%): -141.0260159035714
Buffett classification: The Gruesome
Rule of 40 score: 785.6535088755484
Piotroski F-score: 7 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 899.0586677345132
Total shareholder yield (%): 899.0586677345132 (High Return)
Lynch category:  (confidence: Low)
Screener: long score 1, short score 4, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.91927316758531 (Likely Safe)
ROE archetype: Standard Business
Treasury beta 1y: 5.036024659576632 (R-squared: 0.008645826953831951)
Insider 90-day net shares: 0 (net value USD: 0.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 73.02504816955684, P/B , ROIC , revenue growth 1y , 6m momentum 
Sector percentiles: P/E 67.58832565284179, 6m momentum 
Industry median P/E: 0.34832165205981025; industry median ROIC: 8.620128805291433
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.06628616427626563
Base cash flow: 1514866.44295302
DCF price per share: base 0.2660012719395095, conservative 0.22706667731374813, aggressive 0.31666566180686856
Financial scorecard for MSR.V (Basic Materials — Other Industrial Metals & Mining, Canada)
Report date: 2025-12-31 (annual)
Stock price: 0.3687943262411348
Market cap: 88019048 (USD: 64247480.2919708)
P/B ratio: 6.63040648142218
Debt to equity: 0
Current ratio: 1.58
Return on net tangible assets (%): -12.98689547343576
Buffett classification: The Gruesome
Rule of 40 score: 0
Altman Z-score: 123.36344326497066 (Safe Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -6.4842958459979725, 3m 12.277383766745482, 6m -15.177304964539006, 12m 4915.602836879434, composite 1753.4934534974493 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 4, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: -0.05488018096182775
FCF conversion rate: 0.48851729192681476
Beneish M-score: -2.893366389672905 (Likely Safe)
ROE (%): -10.950416140849832
Asset turnover: 0
Equity multiplier (leverage): 1.020577630045711
ROE archetype: Low Return
Treasury beta 1y: -0.05341389610257763 (R-squared: 1.5577658829356505e-05)
Insider 90-day net shares: 737500 (net value USD: 265789.00)
ROIC (%): -8.173936412764677 (pretax: -10.346754952866679)
Incremental ROIC 3y (%): -3.6929594956600296 (pretax: -4.674632272987377)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 47.71024146544546, ROIC 21.065778517901748, revenue growth 1y , 6m momentum 29.97502081598668
Sector percentiles: P/E , 6m momentum 39.3670183231538
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.05
Base cash flow: -1452008.7591240874
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for MUSH.V (Healthcare — Drug Manufacturers - Specialty & Generic, Canada)
Report date: 2026-04-30 (quarterly)
Stock price: 0.0921985815602837
Market cap: 6717708 (USD: 4903436.496350365)
P/E ratio: 60800.97126104104
P/B ratio: 12.50549442482641
Debt to equity: 0.1359
Current ratio: 1.41
Interest coverage ratio: 159.96080218778488
Return on net tangible assets (%): 25.24447473979498
Buffett classification: The Great
Rule of 40 score: -70.74195289030625
Altman Z-score: -6.013855368175414 (Distress Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.06782251503814272
Total shareholder yield (%): 0.06782251503814272 (Low Return)
Momentum (%): 1m 9.101654846335709, 3m -2.8368794326241, 6m -9.11854103343466, 12m 39.322301024428725, composite 5.2480366834577294 (Strong Uptrend)
Lynch category: Fast Grower (confidence: Medium)
Screener: long score 4, short score 6, recommendation: Neutral
Revenue growth 1y (%): 38.66188713781666
Revenue deceleration: no
Revenue growth consistency score: 59.192651567737734
Accrual ratio: 0.2428502540752166
FCF conversion rate: -2.6638547864728475
Beneish M-score: -1.6598424790659094 (Possible Manipulation)
ROE (%): 28.278123472122758
Net margin (%): 9.776837764532138
Asset turnover: 0.6779566126060691
Equity multiplier (leverage): 4.266289052500541
ROE archetype: Leverage-Driven Returns
FCF z-score: 2.192581516659165
Treasury beta 1y: 0.0022214247789459737 (R-squared: 0.0001036078089936602)
Insider 90-day net shares: 142800 (net value USD: 16422.00)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E 57.18475073313783, P/B 75.366568914956, ROIC , revenue growth 1y 7.624633431085044, 6m momentum 48.68035190615836
Sector percentiles: P/E 35.06446991404012, 6m momentum 39.541547277936964
Industry median P/E: 0.8814835040505258; industry median ROIC: 5.747543732928968
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.05
Base cash flow: -283409.4202898551
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for NAII (Consumer Defensive — Packaged Foods, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 2.4
Market cap: 15060550 (USD: 15060550)
P/B ratio: 0.26150930549833623
Debt to equity: 1.0326
Current ratio: 1.64
Interest coverage ratio: -14.866666666666667
Return on net tangible assets (%): -6.681983837743623
Buffett classification: The Gruesome
Rule of 40 score: 5.533972934097585
Altman Z-score: 0.9069007721592427 (Distress Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0.5444688274996597
Debt paydown yield (%): -22.980568438735638
Total shareholder yield (%): -22.436099611235978 (Minimal or Negative)
Momentum (%): 1m -1.234567901234578, 3m -10.44776119402986, 6m -42.168674698795186, 12m -34.24657534246575, composite -28.68036447569054 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 8, recommendation: Short
Revenue growth 1y (%): 23.34700688312592
Revenue deceleration: no
Accrual ratio: -0.03708210434776966
FCF conversion rate: -0.32544653212711666
Beneish M-score: 0.5154539391311144 (Strong Manipulation Signal)
ROE (%): -6.624358462153109
Net margin (%): -12.149822445183474
Asset turnover: 0.2302672779957233
Equity multiplier (leverage): 2.3677817388364732
ROE archetype: Low Return
FCF z-score: 2.29953219527209
Treasury beta 1y: 0.003956364195547594 (R-squared: 0.0007501413219845526)
Insider 90-day net shares: 10000 (net value USD: 26825.00)
ROIC (%): -4.981629621908956 (pretax: -6.305860280897413)
Incremental ROIC 3y (%): -99.1632628382442 (pretax: -126.12335863149018)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 7.728337236533958, ROIC 68.61826697892272, revenue growth 1y 8.899297423887589, 6m momentum 76.11241217798595
Sector percentiles: P/E , 6m momentum 76.53874004344678
Industry median P/E: 0.5444598070416563; industry median ROIC: 6.765322712696236
Sector median P/E: 1.0302878025850322; sector median ROIC: 7.163828537874342
WACC: 0.05
Base cash flow: -12629000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for NAK (Basic Materials — Other Industrial Metals & Mining, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 1.58
Market cap: 885291648 (USD: 885291648)
P/E ratio: 12.901901756578946
P/B ratio: 25.73680595883491
Debt to equity: 0.078
Current ratio: 0.71
Interest coverage ratio: -28.76279069767442
Return on net tangible assets (%): 49.96931501675873
Buffett classification: The Gruesome
Analyst consensus upside (%): 80.00000000000001
Rule of 40 score: 0
Altman Z-score: -0.3645610388632843 (Distress Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.005975582023358159
Total shareholder yield (%): -0.005975582023358159 (Minimal or Negative)
Momentum (%): 1m -12.707182320441987, 3m -19.796954314720807, 6m -25.82159624413145, 12m 79.54545454545455, composite 20.02108920765531 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 4, short score 7, recommendation: Neutral
Revenue deceleration: no
Accrual ratio: 0.21544004553013374
FCF conversion rate: -0.2327243468383188
Beneish M-score: -2.43366241979808 (Likely Safe)
ROE (%): 70.01497520540416
Asset turnover: 0
Equity multiplier (leverage): 4.006180205105406
ROE archetype: Leverage-Driven Returns
Treasury beta 1y: -0.008917929500676495 (R-squared: 0.001662013831436151)
Insider 90-day net shares: 3630962 (net value USD: 2654864.00)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E 11.240632805995004, P/B 57.78517901748543, ROIC , revenue growth 1y , 6m momentum 38.96752706078268
Sector percentiles: P/E 26.92948362021099, 6m momentum 50.38867295946696
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.07737507344352972
Base cash flow: -112578102.18978101
DCF price per share: base 0, conservative 0, aggressive 0